Area of research
Molecular Biology · Hematology
Research interest
Research focused on Neuroblastoma and BRD4, with related work in Cancer research, Bromodomain, Enhancer. Notable publications include 'PROTAC Bromodomain Inhibitor ARV-825 Displays Anti-Tumor Activity in Neuroblastoma by Repressing Expression of MYCN or c-Myc', 'BRD4 inhibitor MZ1 exerts anti-cancer effects by targeting MYCN and MAPK signaling in neuroblastoma', and 'The BET inhibitor GNE-987 effectively induces anti-cancer effects in T-cell acute lymphoblastic leukemia by targeting enhancer regulated genes'.